Sustained Complete Molecular Remissions After Treatment With Imatinib-Mesylate in Patients With Failure After Allogeneic Stem Cell Transplantation for Chronic Myelogenous Leukemia: Results of a ...
Forbes Health analyzed data from organizations including IHME, the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO) to find the latest longevity statistics.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results